Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial

被引：133
|
作者：
Kelley, John M. [1 ,2 ,3 ,4 ]
Kaptchuk, Ted J. [2 ,3 ]
Cusin, Cristina [3 ,4 ]
Lipkin, Samuel [3 ,4 ]
Fava, Maurizio [3 ,4 ]
机构：
[1] Endicott Coll, Dept Psychol, Beverly, MA 01915 USA
[2] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA USA
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2012年 / 81卷 / 05期
关键词：
D O I：
10.1159/000337053
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [1] A randomized open-label trial of paroxetine versus paroxetine plus sulpiride in the treatment of major depressive disorder
    Uchida, H
    Takeuchi, H
    Nomura, K
    Suzuki, T
    Watanabe, K
    Kashima, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : A16 - A16
  • [2] RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION OF INTRANASAL OXYTOCIN FOR AUTISM SPECTRUM DISORDER
    Spanos, Marina
    Bethea, Terrence
    Alderman, Cheryl
    Johnson, Jacqueline
    Chandrasekhar, Tara
    Sikich, Linmarie
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S162 - S162
  • [3] Escitalopram in the treatment of major depressive disorder: An open-label naturalistic trial in various settings
    Hranov, L.
    Staleva, I.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S92 - S93
  • [4] Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    David G Perahia
    Inmaculada Gilaberte
    Fujun Wang
    John G Watkin
    Michael J Detke
    BMC Psychiatry, 7
  • [5] Duloxetine in the treatment of major depressive disorder: an open-label study
    Hudson, James I.
    Perahia, David G.
    Gilaberte, Inmaculada
    Wang, Fujun
    Watkin, John G.
    Detke, Michael J.
    BMC PSYCHIATRY, 2007, 7 (1) : 43
  • [6] Open-label tiagabine monotherapy for major depressive disorder with anxiety
    Carpenter, LL
    Schecter, JM
    Tyrka, AR
    Mello, AF
    Mello, MF
    Haggarty, R
    Price, LH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 66 - 71
  • [7] MAJOR DEPRESSIVE DISORDER, ANHEDONIA, AND AGOMELATINE: AN OPEN-LABEL STUDY
    Martinotti, G.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Janiri, L.
    Di Giannantonio, M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [8] MAJOR DEPRESSIVE DISORDER, ANHEDONIA AND AGOMELATINE: AN OPEN-LABEL STUDY
    di Giannantonio, M.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Conti, C. M.
    Acciavatti, T.
    Cornelio, M.
    Martinotti, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (01): : 109 - 114
  • [9] An Open-Label, Pilot Study Evaluating the Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder
    Sadavoy, Joel
    Bain, Jerald
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (02) : 230 - 233
  • [10] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, Uri
    Carmeli, Gal
    Chalamish, Yossi
    Braw, Yoram
    Kirsch, Irving
    Shefet, Daphna
    Krieger, Israel
    Mendlovic, Shlomo
    Bloch, Yuval
    Lichtenberg, Pesach
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 707 - 710
12345